Belinostat T1852
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity. Belinostat targets HDAC enzymes, thereby inhibiting tumor cell proliferation, inducing apoptosis, promoting cellular differentiation, and inhibit
CAS nr:
414864-00-9
Purity:
98%
Molecular Weight:
318,35
SMILES:
ONC(=O)/C=C/c1cc(ccc1)S(=O)(=O)Nc1ccccc1
Formula:
C15H14N2O4S
Pathway:
DNA Damage/DNA Repair,Chromatin/Epigenetic
Target:
HDAC,HDAC
